CINECA IRIS Institutional Research Information System

ROMAGNOLO, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.372
EU - Europa 1.873
AS - Asia 956
SA - Sud America 60
OC - Oceania 30
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.315
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.309
IT - Italia 522
CN - Cina 474
IE - Irlanda 281
SE - Svezia 257
FR - Francia 141
DE - Germania 122
SG - Singapore 114
JP - Giappone 113
AT - Austria 111
GB - Regno Unito 84
IN - India 59
FI - Finlandia 55
CA - Canada 53
ES - Italia 51
VN - Vietnam 49
KR - Corea 42
BR - Brasile 41
PL - Polonia 36
UA - Ucraina 35
BE - Belgio 34
NL - Olanda 30
TR - Turchia 28
AU - Australia 26
HK - Hong Kong 26
CH - Svizzera 17
PT - Portogallo 17
GR - Grecia 16
RO - Romania 16
TW - Taiwan 14
CZ - Repubblica Ceca 10
MX - Messico 10
AR - Argentina 9
RU - Federazione Russa 9
IR - Iran 6
SN - Senegal 6
UZ - Uzbekistan 6
BG - Bulgaria 5
EG - Egitto 5
ID - Indonesia 5
PH - Filippine 5
SI - Slovenia 5
CL - Cile 4
CO - Colombia 4
DK - Danimarca 4
MY - Malesia 4
NZ - Nuova Zelanda 4
CY - Cipro 3
HR - Croazia 3
IL - Israele 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CM - Camerun 2
HU - Ungheria 2
MA - Marocco 2
MT - Malta 2
RS - Serbia 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
EC - Ecuador 1
EE - Estonia 1
EU - Europa 1
GH - Ghana 1
IS - Islanda 1
KW - Kuwait 1
MD - Moldavia 1
PE - Perù 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 6.315
Salva come PNG Salva come JPEG
Città #
Chandler 629
Dublin 279
Beijing 227
Ann Arbor 191
Torino 188
Ashburn 183
Fairfield 172
Houston 116
Nyköping 116
Vienna 104
Wilmington 94
Redwood City 91
Woodbridge 88
Medford 87
Princeton 79
Singapore 74
Villeurbanne 74
Seattle 59
Dearborn 58
Cambridge 48
Boston 40
Jacksonville 38
Dong Ket 37
Boardman 30
Hangzhou 30
Turin 29
Pisa 28
Brussels 27
Fremont 26
New York 26
Milan 24
Seoul 21
Warsaw 20
Helsinki 19
Nanjing 19
Tokyo 18
Chengdu 17
Madrid 17
Shanghai 15
Norwalk 14
Ottawa 14
Hebei 13
Washington 13
Guangzhou 12
Los Angeles 12
Xian 12
Central District 11
São Paulo 11
Dallas 9
Hefei 9
London 9
Taipei 9
Toronto 9
Wuhan 9
Barcelona 8
Fort Worth 8
Hong Kong 8
Riverton 8
San Diego 8
Amsterdam 7
Falls Church 7
Jinan 7
Mumbai 7
Rome 7
Silver Spring 7
Buenos Aires 6
Sydney 6
Verona 6
Bethesda 5
Bologna 5
Bricherasio 5
Chongqing 5
Duncan 5
Hamburg 5
Hiroshima 5
Istanbul 5
Melbourne 5
Rochester 5
Zhengzhou 5
Ahmedabad 4
Aracaju 4
Atlanta 4
Bucharest 4
Chicago 4
Düsseldorf 4
Gent 4
Groslay 4
Medellín 4
Nanchang 4
Napoli 4
New Delhi 4
Nuremberg 4
Orio Canavese 4
Phoenix 4
Prague 4
Redmond 4
Sanayi 4
Santa Clara 4
Santiago 4
Upper Marlboro 4
Totale 3.843
Salva come PNG Salva come JPEG
Nome #
Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease 650
Levodopa-carbidopa intestinal gel infusion and weight loss in Parkinson's disease 373
Progranulin expression in brain tissue and cerebrospinal fluidlevels in multiple sclerosis 355
Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patients. 318
Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation. 267
Does intraoperative microrecording really increase the risk of hemorrhagic complications in deep brain stimulation? 208
Beyond 35 years of Parkinson’s disease: a comprehensive clinical and instrumental assessment 133
Reverse blood pressure dipping as marker of dysautonomia in Parkinson disease 116
Neurological comorbidity and severity of COVID-19 101
What Happens When I Watch a Ballet and I Am Dyskinetic? A fMRI Case Report in Parkinson Disease. 99
Pure autonomic failure versus prodromal dysautonomia in Parkinson’s disease: Insights from the bedside 89
Role of the cingulate cortex in dyskinesias-reduced-self-awareness: An fMRI study on Parkinson's disease patients 88
Trait impulsivity and response-inhibition in Parkinson Disease. An fMRI study. 84
Cardiovascular autonomic neuropathy and falls in Parkinson disease: a prospective cohort study 82
Cardiac organ damage in patients with Parkinson's disease and reverse dipping 82
Advanced therapies in Parkinson's disease: Long-term retrospective study 79
CIDP-like neuropathies in graft versus host disease 76
Verbal communication about drug dosage balances drug reduction in Parkinson's disease: Behavioral and electrophysiological evidences 75
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications 75
Blood pressure circadian rhythm alterations in alpha-synucleinopathies 73
Transdermal rotigotine in dihydropteridine reductase deficiency 72
Pisa syndrome in Parkinson's disease is associated with specific cognitive alterations 72
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response? 70
Neurodegeneration and iron accumulation in deep grey matter nuclei in multiple sclerosis. 69
Earlier versus later subthalamic deep brain stimulation in Parkinson's disease 69
Detection of orthostatic hypotension with ambulatory blood pressure monitoring in parkinson’s disease 69
Orthostatic hypotension in Parkinson disease: Impact on health care utilization 68
Deep brain stimulation in uncommon tremor disorders: indications, targets, and programming 68
Peripheral neuropathy associated with levodopa-carbidopa intestinal infusion: A long-term prospective assessment 66
Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study 66
Subcutaneous vs. intravenous immunoglobulin in CIDP: pharmacokinetic and clinical response 64
Autonomic dysfunction in Parkinson's disease: A prospective cohort study 63
Deep brain stimulation fine-tuning in Parkinson's disease: Short pulse width effect on speech 63
Orthostatic hypotension in Parkinson's disease: Does it matter if asymptomatic? 62
Long-term effect of levodopa-carbidopa intestinal gel on axial signs in Parkinson’s disease 62
Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic 61
Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson's disease patients with dysarthria? 60
A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion 59
Should We Consider Deep Brain Stimulation Discontinuation in Late-Stage Parkinson’s Disease? 59
Peripheral Nerve Ultrasonography in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: Correlations with Clinical and Neurophysiological Data 58
COVID-19 and Parkinson's Disease: What We Know So Far? 57
Parkinsonism–hyperpyrexia syndrome and deep brain stimulation 57
Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: A neuropathological study 55
Motor and non-motor outcomes of subthalamic deep brain stimulation in a case of juvenile PARK-PINK1 54
Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson’s disease 54
Differential response to pallidal deep brain stimulation among monogenic dystonias: Systematic review and meta-analysis 52
Levodopa/Carbidopa Intestinal Gel Long-Term Outcome in Parkinson's Disease: Focus on Dyskinesia 52
Effects of intestinal Levodopa infusion on freezing of gait in Parkinson disease 52
Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis 50
A new index to assess turning quality and postural stability in patients with Parkinson's disease 50
Current Directions in Deep Brain Stimulation for Parkinson’s Disease—Directing Current to Maximize Clinical Benefit 49
Home monitoring of motor fluctuations in Parkinson’s disease patients 48
Tuning Deep Brain Stimulation related depression by frequency modulation: a case report 48
COVID-19 in Parkinson's disease: Report on prevalence and outcome 47
Low frequency subthalamic stimulation and event-related potentials in Parkinson disease 47
Onset of Covid-19 with impaired consciousness and ataxia: a case report 45
Efficacy of safinamide as add-on therapy after subthalamic nucleus deep brain stimulation in Parkinson disease 45
Prevalence and burden of dysautonomia in advanced Parkinson's disease 44
Subcutaneous "bolus" immunoglobulin dose in CIDP: A proof-of concept study 44
Peripheral neuropathy as marker of severe Parkinson's disease phenotype 43
Deep brain stimulation outcomes in the malignant end of Parkinson's disease spectrum 43
Video analysis of long-term effects of levodopa-carbidopa intestinal gel on gait and posture in advanced Parkinson’s disease 42
Preliminary evidence from a Line-Bisection Task for visuospatial neglect in Parkinson's disease 41
Telemedicine in Neurological Disorders: Opportunities and Challenges 41
Effect of subthalamic deep brain stimulation on posture in Parkinson's disease: A blind computerized analysis 41
Machine learning applied to ambulatory blood pressure monitoring: a new tool to diagnose autonomic failure? 41
Levodopa-Induced Dyskinesias and Dyskinesias-Reduced-Self-Awareness in Parkinson’s Disease: A Neurocognitive Approach 39
Neurological comorbidities and COVID-19-related case fatality: A cohort study 39
Focal seizures with impaired awareness as long-term neurological complication of COVID-19: a case report 39
Levodopa and neuropathy risk in patients with Parkinson disease: Effect of COMT inhibition 38
Orthostatic hypotension and REM sleep behaviour disorder: Impact on clinical outcomes in α-synucleinopathies 37
Functional neurological disorders in Parkinson disease 37
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials 37
Subthalamic deep brain stimulation and trunk posture in Parkinson's disease 35
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders 35
Levodopa-Induced Neuropathy: A Systematic Review 33
Early reversible leukoencephalopathy and unilateral sixth cranial nerve palsy in mild COVID-19 infection 31
Levodopa-Induced Dyskinesias and Dyskinesias-Reduced-Self-Awareness in Parkinson’s Disease: A Neurocognitive Approach 26
Multiple sclerosis relapses: a multivariable analysis of residual disability determinants 25
Differential impact of individual autonomic domains on clinical outcomes in Parkinson's disease 23
Reply to: "Autonomic dysfunction in Parkinson's disease: The hidden game changer?" 22
Burden of caregiving for cardiovascular dysautonomia in Parkinson's disease 20
SARS-CoV-2 vaccination, Parkinson's disease, and other movement disorders: case series and short literature review 18
How resistant are levodopa-resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease 12
Effects of dopaminergic therapy on sleep quality in fluctuating Parkinson’s disease patients 10
15-Year Subthalamic Deep Brain Stimulation outcome in a Parkinson’s disease patient with Parkin gene mutation: a case report 9
Neurological symptoms in adults with Gaucher disease: a systematic review 4
Axial symptoms as main predictors of short-term subthalamic stimulation outcome in Parkinson's disease 3
Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations 3
Hypotensive episodes at 24-h ambulatory blood pressure monitoring predict adverse outcomes in Parkinson’s disease 3
Deep Brain Stimulation Outcomes in Parkinson's Disease Patients with Cognitive Impairment: Implications and Considerations 2
Incidence and predictors of postural abnormalities in Parkinson's disease: a PPMI cohort study 2
Effects of Continuous Dopaminergic Stimulation on Parkinson's Disease Gait: A Longitudinal Prospective Study with Levodopa Intestinal Gel Infusion 2
Totale 6.549
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.360
article - articoli 0
book - libri 0
conference - conferenze 406
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.766
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020775 0 16 36 81 71 83 98 77 80 90 66 77
2020/2021820 61 121 82 47 66 55 47 59 66 65 54 97
2021/20221.056 56 35 47 111 61 49 51 50 47 85 262 202
2022/20231.590 166 173 51 173 154 391 90 89 164 35 70 34
2023/2024756 111 129 42 28 76 96 26 46 4 57 41 100
2024/202535 31 4 0 0 0 0 0 0 0 0 0 0
Totale 6.549